How many days can Kawasaki disease be cured?

Written by Li Jiao Yan
Neonatology
Updated on September 26, 2024
00:00
00:00

Kawasaki disease is a syndrome of mucocutaneous lymph node syndrome, the cause of which is unclear, as is the pathogenesis of the disease. The pathological changes are mainly systemic vasculitis, which is prone to secondary damage to the coronary arteries. It has a relatively long course. If fever occurs, the fever can persist for 1-2 weeks. Generally, special medications such as aspirin are required for treatment. Usually, treatment is for 3 days, and after the fever subsides, the dosage is gradually reduced, maintained for 6-8 weeks. If there is secondary coronary artery damage, the duration might be longer. In cases of severe coronary damage, the duration of the disease may be several months or even years, depending on the specific condition of the disease. Kawasaki disease is a self-limiting disease. Usually, if there is no significant coronary artery damage, after symptom control, comprehensive examinations are conducted 1 month, 3 months, 6 months, and 1-2 years after discharge, mainly heart examinations such as electrocardiograms and echocardiograms. If there is a combination of coronary artery aneurysms, long-term follow-up is required, with an examination every six months to one year until the coronary aneurysm disappears or if there is combined damage to the coronary artery structure, long-term follow-up is needed.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 26sec home-news-image

How long does it take to cure Kawasaki disease?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has unclear etiology and pathogenesis. The primary pathological change is systemic vasculitis, frequently affecting the coronary arteries. Kawasaki disease is considered a self-limiting condition, with most cases having a good prognosis; recurrence occurs in 1% to 2% of affected children. If associated with coronary artery damage and not effectively treated, 15% to 25% of these cases can develop coronary artery aneurysms. Typically, coronary artery aneurysms resolve within two years of onset, but often leave residual arterial wall thickening and reduced elasticity. Large aneurysms do not disappear completely and can lead to thrombosis or stenosis. Kawasaki disease is also one of the main causes of acquired heart disease in children. Therefore, active and effective treatment of Kawasaki disease can result in recovery. However, if there is accompanying coronary artery damage, the prognosis can vary depending on the extent of the damage. Severe coronary artery damage might lead to long-term heart disease.

doctor image
home-news-image
Written by Yao Li Qin
Pediatrics
46sec home-news-image

Kawasaki disease incubation period

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a common pediatric fever and rash illness, primarily a systemic small vessel vasculitis. Kawasaki disease is not contagious, so it has no incubation period; only infectious diseases have incubation periods. If it were contagious, typical manifestations would include persistent high fever, pinpoint appearances around the eyes and mouth, typical rash, swelling of the hands and feet, and non-purulent swelling of the cervical lymph nodes. Therefore, Kawasaki disease has no incubation period and is a vasculitis mediated by immune mechanisms.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 45sec home-news-image

Is Kawasaki disease easy to treat?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a self-limiting disease but is an acute systemic vasculitis commonly seen in infants and children under the age of 5. The primary clinical manifestations include non-suppurative cervical lymphadenopathy, oral mucosal lesions, conjunctival congestion, prolonged fever, polymorphous rash, and hard swelling of the hands and feet with fingertip desquamation. Cardiovascular damage is the most severe complication of Kawasaki disease and can lead to coronary artery aneurysms and coronary artery dilation. If Kawasaki disease is not treated promptly, the incidence of developing coronary artery aneurysms is 15%-25%, making Kawasaki disease one of the most common causes of acquired heart disease in infants and young children. Therefore, timely treatment of Kawasaki disease is crucial, generally involving anti-inflammatory treatment, immune support, and symptomatic management. If there is no concomitant coronary artery damage, treatment involves symptomatic management. If there is coronary artery damage, the treatment duration will be longer and regular follow-up is necessary. The course of the disease can extend over months or even years, thus treatment of Kawasaki disease needs to be tailored based on the individual's condition and clinical symptoms.

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
51sec home-news-image

How long does Kawasaki disease require hospitalization?

Kawasaki disease is an autoimmune vasculitis, primarily concerning because it affects the coronary arteries of the heart. Without effective treatment, some cases can lead to coronary artery dilation and even the formation of coronary artery aneurysms. Therefore, hospitalization is generally recommended during the acute phase of Kawasaki disease. During hospitalization, treatment typically involves the use of intravenous immunoglobulin and aspirin. After treatment with intravenous immunoglobulin, the body temperature generally begins to decrease gradually. Once the body temperature has stabilized for about three days and there are no complications, the patient can usually be discharged, so most hospital stays last about 5-7 days. (Medication should be taken under the guidance of a doctor.)

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
52sec home-news-image

Is Kawasaki disease characterized by eye discharge?

Kawasaki disease is an autoimmune vasculitis that can affect blood vessels throughout the body and various organs, but the most severe impact is typically on the coronary arteries, which can lead to dilation of the coronary arteries or the possibility of forming coronary artery aneurysms. The disease can cause conjunctival congestion, but this is a manifestation of aseptic conjunctivitis, meaning it does not cause, nor does it result in, purulent secretions, in other words, it does not cause eye discharge. Therefore, if a patient with Kawasaki disease has purulent eye discharge, it is possible that they have a concurrent bacterial conjunctivitis. Thus, generally, eyes affected by Kawasaki disease do not have eye discharge but may appear dry and red.